Tag: bsx

Boston Scientific (BSX) is rated Hold as strong organic growth and clinical momentum are offset by a valuation that already reflects much of the upside. The key question is whether BSX can keep growing fast enough to justify 13.4x EV/EBITDA while managing a $12.6B debt load.

Read note